Wealth Enhancement Advisory Services LLC boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 8,370.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 516,868 shares of the company's stock after buying an additional 510,766 shares during the period. Wealth Enhancement Advisory Services LLC owned approximately 0.31% of Astera Labs worth $83,181,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company's stock worth $2,690,907,000 after acquiring an additional 1,693,918 shares during the period. State Street Corp increased its stake in Astera Labs by 9.1% in the third quarter. State Street Corp now owns 2,339,451 shares of the company's stock valued at $458,065,000 after acquiring an additional 195,992 shares during the last quarter. 1832 Asset Management L.P. raised its position in Astera Labs by 151.4% during the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company's stock valued at $139,563,000 after purchasing an additional 929,600 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in Astera Labs by 46.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company's stock valued at $295,203,000 after purchasing an additional 479,360 shares in the last quarter. Finally, Amundi lifted its stake in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company's stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. 60.47% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on ALAB shares. Barclays set a $165.00 price target on Astera Labs in a research note on Thursday, January 15th. Weiss Ratings lowered Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, February 23rd. Loop Capital started coverage on Astera Labs in a research report on Thursday, March 5th. They issued a "buy" rating and a $250.00 target price on the stock. Northland Securities boosted their target price on Astera Labs from $175.00 to $195.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 9th. Finally, Royal Bank Of Canada began coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an "outperform" rating and a $225.00 target price for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and an average price target of $202.22.
Read Our Latest Research Report on ALAB
Astera Labs Trading Down 8.0%
NASDAQ:ALAB opened at $116.04 on Monday. The stock's 50-day moving average is $144.10 and its 200-day moving average is $166.05. The stock has a market cap of $19.75 billion, a P/E ratio of 95.11, a price-to-earnings-growth ratio of 2.28 and a beta of 1.75. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90.
Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same period last year, the company earned $0.37 EPS. The firm's revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.
Insider Activity at Astera Labs
In related news, CFO Michael Truett Tate sold 12,001 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the completion of the sale, the chief financial officer directly owned 192,083 shares in the company, valued at $23,781,796.23. This represents a 5.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jack R. Lazar sold 7,500 shares of the firm's stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $119.80, for a total value of $898,500.00. Following the transaction, the director directly owned 87,351 shares of the company's stock, valued at approximately $10,464,649.80. This represents a 7.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 384,292 shares of company stock valued at $48,724,919 in the last quarter. Insiders own 12.50% of the company's stock.
Astera Labs Company Profile
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report